<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001296995</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>4</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.001</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>03/31/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001593899</issuerCik>
        <issuerName>Atea Pharmaceuticals, Inc.</issuerName>
        <issuerCusip>04683R106</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <street1 xmlns="http://www.sec.gov/edgar/common">225 Franklin Street</street1>
          <street2 xmlns="http://www.sec.gov/edgar/common">Suite 2100</street2>
          <city xmlns="http://www.sec.gov/edgar/common">Boston</city>
          <stateOrCountry xmlns="http://www.sec.gov/edgar/common">MA</stateOrCountry>
          <zipCode xmlns="http://www.sec.gov/edgar/common">02110</zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>JPM Partners LLC</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>5866025</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>5866025</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>5866025</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>6.9</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Jean-Pierre Sommadossi</reportingPersonName>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>3010428</soleVotingPower>
        <sharedVotingPower>5866025</sharedVotingPower>
        <soleDispositivePower>3010428</soleDispositivePower>
        <sharedDispositivePower>5866025</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>8876453</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>10.1</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Atea Pharmaceuticals, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>225 Franklin Street, Suite 2100, Boston, MA 02110.</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Each of the following is hereinafter individually referred to as a "Reporting Person" and collectively as the "Reporting Persons."  This statement is filed on behalf of:

JPM Partners LLC; and
Jean-Pierre Sommadossi</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>The business address of JPM Partners LLC is  2 Avery Street #21E, Boston, MA 02111. The business address of Dr. Sommadossi is c/o Atea Pharmaceuticals, Inc., 225 Franklin Street, Suite 2100, Boston, MA 02110.</principalBusinessOfficeOrResidenceAddress>
        <citizenship>JPM Partners LLC is a Delaware limited liability company. Dr. Sommadossi is a citizen of the United States.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>The information contained on the cover pages to this Schedule 13G is incorporated by reference to this Item 4.

The ownership information below represents beneficial ownership of shares of Common Stock as of March 31, 2025, based upon 85,579,475 shares of Common Stock outstanding as of May 9, 2025, as disclosed in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 12, 2025.

JPM Partners LLC is the record holder of 5,866,025 shares of Common Stock. Dr. Sommadossi is the manager of JPM Partners LLC and may be deemed to share beneficial ownership of the securities held by JPM Partner LLC. Dr. Sommadossi beneficially owns an additional 3,010,428 shares of Common Stock, which includes 2,709,488 shares of Common Stock subject to stock options that are currently exercisable or will become exercisable within 60 days of March 31, 2025.</amountBeneficiallyOwned>
        <classPercent>See Item 11 of each of the cover pages hereto.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>Sole power to vote or to direct the vote: See Item 5 of each of the cover pages hereto.</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>Shared power to vote or direct the vote: See Item 6 of each of the cover pages hereto.</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>Sole power to dispose or to direct the disposition of: See Item 7 of each of the cover pages hereto.</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>Shared power to dispose or to direct the disposition of: See Item 8 of each of the cover pages hereto.</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>Y</notApplicableFlag>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>JPM Partners LLC</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Jean-Pierre Sommadossi</signature>
        <title>Jean-Pierre Sommadossi, Manager</title>
        <date>05/14/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Jean-Pierre Sommadossi</reportingPersonName>
      <signatureDetails>
        <signature>Jean-Pierre Sommadossi</signature>
        <title>Jean-Pierre Sommadossi</title>
        <date>05/14/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureComments>
99:        Joint Filing Agreement (previously filed).</signatureComments>
  </formData>
</edgarSubmission>
